Access in the UK is restricted to approved clinical trial participants
10.1016/j.regpep.2004.08.024 68
For patients who start on 2.4 mg and then hit a frustrating plateau, or for those with a very high baseline BMI who may need a stronger metabolic push, this creates a legitimate, evidence-based escalation path rather than forcing an early switch to another drug class, Balazs, who was not involved in the study, told Fox News Digital
When weight reduction exceeds approximately 1.5 kg per week during early therapy, clinicians should remain alert
Source : IBGE Sales of weight-loss drugs are expected to remain concentrated in high-income countries, such as the US and parts of Europe, where pharmaceutical companies like Novo Nordisk and Eli Lilly, with brands such as Ozempic and Wegovy, have been setting revenue records